Cargando…
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
Removal of colorectal adenomas is an effective strategy to reduce colorectal cancer (CRC) mortality rates. However, as only a minority of adenomas progress to cancer, such strategies may lead to overtreatment. The present study aimed to characterize adenomas by in‐depth molecular profiling, to obtai...
Autores principales: | Komor, Malgorzata A., de Wit, Meike, van den Berg, Jose, Martens de Kemp, Sanne R., Delis‐van Diemen, Pien M., Bolijn, Anne S., Tijssen, Marianne, Schelfhorst, Tim, Piersma, Sander R., Chiasserini, Davide, Sanders, Joyce, Rausch, Christian, Hoogstrate, Youri, Stubbs, Andrew P., de Jong, Mark, Jenster, Guido, Carvalho, Beatriz, Meijer, Gerrit A., Jimenez, Connie R., Fijneman, Remond J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027554/ https://www.ncbi.nlm.nih.gov/pubmed/31411736 http://dx.doi.org/10.1002/ijc.32627 |
Ejemplares similares
-
Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018) -
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature
por: Martens-de Kemp, Sanne R., et al.
Publicado: (2022) -
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017) -
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
por: Sillars-Hardebol, Anke H., et al.
Publicado: (2010) -
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)